Latest Post

March 08, 2012

Supply Chain Integrity Reduces Threats of Counterfeit Drug Products

<span style="color: #000000;">In a recent Flash Report, Rx-360.org offered a summary of the proposed USP Chapter 1083 &ndash; Good Distribution Practices &ndash; Supply Chain Integrity.&nbsp; In its report, Rx-360 noted that &ldquo;globalization of all aspects of the pharmaceutical business has driven the need to address the threats of counterfeit or adulterated medication, devices and components, for which there have been several high-profile examples over the last few years.&rdquo;</span>
West Pharma

Fran DeGrazio

VP, Scientific Affairs & Technical Services

Categories

Search the Blog

Archive